Literature DB >> 32711050

HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.

Yoshifumi Sato1, Md Mostafizur Rahman1, Masaki Haneda1, Tomonori Tsuyama2, Tomoya Mizumoto1, Tatsuya Yoshizawa1, Tadahiro Kitamura3, Frank J Gonzalez4, Ken-Ichi Yamamura5, Kazuya Yamagata6.   

Abstract

Hepatocyte nuclear factor 1α (HNF1α) is a transcription factor required for normal insulin secretion and maintenance of β-cell number in the pancreas. HNF1α is also expressed in pancreatic α-cells, but its role in these cells is unknown. The aim of this study was to clarify the role of HNF1α in α-cells. Male Hnf1a+/- mice with a mixed background were backcrossed to outbred ICR mice. Glucose tolerance, glucagon and insulin secretion, islet histology, and gene expression were investigated in ICR Hnf1a-/- and Hnf1a+/+ mice. Regulation of Slc5a1 (encoding sodium glucose cotransporter 1 [SGLT1]) expression by HNF1α and the effect of SGLT1 inhibition on glucagon secretion were also explored. ICR Hnf1a-/- mice were glucose intolerant and exhibited impaired glucose-stimulated insulin secretion. The β-cell area of ICR mice was decreased in Hnf1a-/- mice, but the α-cell area in the pancreas was similar between Hnf1a-/- and Hnf1a+/+ mice. Hnf1a-/- mice showed higher fasting glucagon levels and exhibited inadequate suppression of glucagon after glucose load. In addition, glucagon release in response to hypoglycemia was impaired in Hnf1a-/- mice, and glucagon secretion after 1.1 mM glucose administration, was also decreased in Hnf1a-/- islets. Slc5a1 expression was decreased in Hnf1a-/- islets, while HNF1α activated the Slc5a1 promoter in αTC1-6 cells. Inhibition of SGLT1 suppressed 1.1 mM glucose-stimulated glucagon secretion in islets and αTC1-6 cells, but SGLT1 inhibition had no additional inhibitory effect in HNF1α-deficient cells. Our findings indicate that HNF1α modulates glucagon secretion in α-cells through the regulation of Slc5a1.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucagon; Hepatocyte nuclear factor (HNF) 1α; Maturity-onset diabetes of the young (MODY); Pancreatic α-cell; Sodium-glucose cotransporter (SGLT)

Mesh:

Substances:

Year:  2020        PMID: 32711050      PMCID: PMC8865093          DOI: 10.1016/j.bbadis.2020.165898

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  49 in total

1.  Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.

Authors:  M Lehto; T Tuomi; M M Mahtani; E Widén; C Forsblom; L Sarelin; M Gullström; B Isomaa; M Lehtovirta; A Hyrkkö; T Kanninen; M Orho; S Manley; R C Turner; T Brettin; A Kirby; J Thomas; G Duyk; E Lander; M R Taskinen; L Groop
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes.

Authors:  Kazuya Yamagata; Takao Nammo; Makoto Moriwaki; Arisa Ihara; Katsumi Iizuka; Qin Yang; Tomomi Satoh; Ming Li; Rikako Uenaka; Kohei Okita; Hiromi Iwahashi; Qian Zhu; Yang Cao; Akihisa Imagawa; Yoshihiro Tochino; Toshiaki Hanafusa; Jun-ichiro Miyagawa; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

3.  Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.

Authors:  Caroline Bonner; Julie Kerr-Conte; Valéry Gmyr; Gurvan Queniat; Ericka Moerman; Julien Thévenet; Cédric Beaucamps; Nathalie Delalleau; Iuliana Popescu; Willy J Malaisse; Abdullah Sener; Benoit Deprez; Amar Abderrahmani; Bart Staels; François Pattou
Journal:  Nat Med       Date:  2015-04-20       Impact factor: 53.440

4.  Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1α in mouse β-cells.

Authors:  Tsuyoshi Ohki; Yoshifumi Sato; Tatsuya Yoshizawa; Ken-ichi Yamamura; Kentaro Yamada; Kazuya Yamagata
Journal:  Biochem Biophys Res Commun       Date:  2012-08-01       Impact factor: 3.575

Review 5.  Evidence should trump intuition by preferring inbred strains to outbred stocks in preclinical research.

Authors:  Michael F W Festing
Journal:  ILAR J       Date:  2014

6.  Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative.

Authors:  K Yamagata; Q Yang; K Yamamoto; H Iwahashi; J Miyagawa; K Okita; I Yoshiuchi; J Miyazaki; T Noguchi; H Nakajima; M Namba; T Hanafusa; Y Matsuzawa
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

7.  Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1).

Authors:  Lubing Zhou; Ellen V Cryan; Michael R D'Andrea; Stanley Belkowski; Bruce R Conway; Keith T Demarest
Journal:  J Cell Biochem       Date:  2003-10-01       Impact factor: 4.429

8.  Role of Sp1 and HNF1 transcription factors in SGLT1 regulation during chronic intestinal inflammation.

Authors:  Ramesh Kekuda; Prosenjit Saha; Uma Sundaram
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-03-13       Impact factor: 4.052

9.  Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes.

Authors:  Yoshifumi Sato; Masahiro Inoue; Tatsuya Yoshizawa; Kazuya Yamagata
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

10.  A suppressor locus for MODY3-diabetes.

Authors:  Miguel A Garcia-Gonzalez; Claire Carette; Alessia Bagattin; Magali Chiral; Munevver Parla Makinistoglu; Serge Garbay; Géraldine Prévost; Cécile Madaras; Yann Hérault; Michel Leibovici; Marco Pontoglio
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more
  3 in total

Review 1.  HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.

Authors:  Li-Mei Li; Bei-Ge Jiang; Liang-Liang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

Review 2.  Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters.

Authors:  Sarah L Armour; Alexander Frueh; Jakob G Knudsen
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 3.  HNF1A Mutations and Beta Cell Dysfunction in Diabetes.

Authors:  Yasutaka Miyachi; Takashi Miyazawa; Yoshihiro Ogawa
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.